| P50 | author | Charles T Quinn | Q42365105 |
| P2093 | author name string | Charles T Quinn | |
| P2860 | cites work | The effect of UGT1A1 promoter polymorphism in the development of hyperbilirubinemia and cholelithiasis in hemoglobinopathy patients | Q21559550 |
| | What are biomarkers? | Q24613362 |
| | Early complication in sickle cell anemia children due to A(TA)nTAA polymorphism at the promoter of UGT1A1 gene | Q30448607 |
| | Improved survival of children and adolescents with sickle cell disease | Q33839801 |
| | Secretory phospholipase A(2) predicts impending acute chest syndrome in sickle cell disease. | Q33922856 |
| | Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study | Q33937789 |
| | Association of G6PD with lower haemoglobin concentration but not increased haemolysis in patients with sickle cell anaemia | Q34005594 |
| | Haptoglobin, alpha-thalassaemia and glucose-6-phosphate dehydrogenase polymorphisms and risk of abnormal transcranial Doppler among patients with sickle cell anaemia in Tanzania. | Q34131141 |
| | Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment | Q34187983 |
| | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia | Q34256214 |
| | Phospholipase A2 levels in acute chest syndrome of sickle cell disease | Q34379606 |
| | National trends in incidence rates of hospitalization for stroke in children with sickle cell disease | Q34601055 |
| | Monocyte protein signatures of disease severity in sickle cell anemia. | Q34660975 |
| | Doppler-defined pulmonary hypertension and the risk of death in children with sickle cell disease followed for a mean of three years | Q34806446 |
| | Fetal hemoglobin in sickle cell anemia | Q35114500 |
| | Survival of children with sickle cell disease | Q35690101 |
| | Fetal hemoglobin in sickle cell anemia: molecular characterization of the unusually high fetal hemoglobin phenotype in African Americans. | Q35827878 |
| | Risk factors and prediction of outcomes in children and adolescents who have sickle cell anemia. | Q35931484 |
| | Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE) | Q35951573 |
| | A network model to predict the risk of death in sickle cell disease | Q36007731 |
| | Predicting clinical severity in sickle cell anaemia. | Q36118601 |
| | Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease | Q36151344 |
| | Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newborn Cohort. | Q36384757 |
| | Mortality rates and age at death from sickle cell disease: U.S., 1979-2005. | Q36577872 |
| | Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease | Q36677950 |
| | DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease | Q36800496 |
| | Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemia. | Q37178468 |
| | Control of fetal hemoglobin: new insights emerging from genomics and clinical implications | Q37379477 |
| | Glucose-6-Phosphate Dehydrogenase Deficiency in Brazilian Children With Sickle Cell Anemia is not Associated With Clinical Ischemic Stroke or High-Risk Transcranial Doppler. | Q40028038 |
| | Serum biomarkers for identifying acute chest syndrome among patients who have sickle cell disease and present to the emergency department | Q40501265 |
| | Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment | Q40738128 |
| | Impact of glucose-6-phosphate dehydrogenase deficiency on sickle cell anaemia expression in infancy and early childhood: a prospective study | Q42244698 |
| | The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). | Q43244775 |
| | Sickle cell disease as a cause of osteonecrosis of the femoral head | Q44105081 |
| | The association between tricuspid regurgitation velocity and 5-year survival in a North West London population of patients with sickle cell disease in the United Kingdom. | Q44618194 |
| | Pulmonary hypertension as a risk factor for death in patients with sickle cell disease | Q44777573 |
| | Development and validation of a pediatric severity index for sickle cell patients | Q44949708 |
| | Prediction of adverse outcomes in children with sickle cell disease | Q44990679 |
| | G6PD deficiency, absence of alpha-thalassemia, and hemolytic rate at baseline are significant independent risk factors for abnormally high cerebral velocities in patients with sickle cell anemia | Q46388586 |
| | The alpha-globin genotype does not influence sickle cell disease severity in a retrospective cross-validation study of the pediatric severity score | Q46502955 |
| | The influence of uridine diphosphate glucuronosyl transferase 1A promoter polymorphisms, beta-globin gene haplotype, co-inherited alpha-thalassemia trait and Hb F on steady-state serum bilirubin levels in sickle cell anemia | Q46590318 |
| | Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority tria | Q47100582 |
| | UGT1A1 variation and gallstone formation in sickle cell disease | Q47317656 |
| | Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography | Q47906551 |
| | UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia | Q50169464 |
| | Influence of bilirubin uridine diphosphate-glucuronosyltransferase 1A promoter polymorphisms on serum bilirubin levels and cholelithiasis in children with sickle cell anemia | Q50179471 |
| | G6PD deficiency and absence of α-thalassemia increase the risk for cerebral vasculopathy in children with sickle cell anemia | Q50442869 |
| | Influence of the βs haplotype and α-thalassemia on stroke development in a Brazilian population with sickle cell anaemia. | Q50479766 |
| | Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2. | Q50712413 |
| | The effect of hydroxcarbamide therapy on survival of children with sickle cell disease. | Q51065755 |
| | Elevated tricuspid regurgitant velocity as a marker for pulmonary hypertension in children with sickle cell disease: less prevalent and predictive than previously thought? | Q53040931 |
| | The use of transcranial ultrasonography to predict stroke in sickle cell disease. | Q55043495 |
| | Mortality in sickle cell disease. Life expectancy and risk factors for early death. | Q55065788 |
| | Fetal hemoglobin in sickle cell anemia: a glass half full? | Q57624642 |
| | G6PD deficiency and stroke in the CSSCD | Q57624755 |
| | Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London | Q58320124 |
| | Effects of thalassemia and microcytosis on the hematologic and vasoocclusive severity of sickle cell anemia | Q71349152 |
| | Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia | Q72655161 |
| | Post-natal decline of fetal haemoglobin in homozygous sickle cell disease: relationship to parenteral Hb F levels | Q72678055 |
| | Cerebrovascular accidents in sickle cell disease: rates and risk factors | Q73982009 |
| | Secretory phospholipase A2 levels in patients with sickle cell disease and acute chest syndrome | Q79785208 |
| | Clinical differences between children and adults with pulmonary hypertension and sickle cell disease | Q81397158 |
| | Association of UGT1A1 polymorphism with prevalence and age at onset of cholelithiasis in sickle cell anemia | Q81400573 |
| P433 | issue | 7 | |
| P921 | main subject | sickle-cell disease | Q185034 |
| P304 | page(s) | 679-688 | |
| P577 | publication date | 2016-03-23 | |
| | 2016-04-01 | |
| P1433 | published in | Experimental Biology and Medicine | Q15716535 |
| P1476 | title | Minireview: Clinical severity in sickle cell disease: the challenges of definition and prognostication | |
| P478 | volume | 241 | |